Date 20/3/2009 Author Nabila Ahmed Source The Australian Financial Review -- Page: 50 Administrators from Ferrier Hodgson have been appointed to Australian-listed biotechnology group Ventracor. The move follows the failure of attempts to secure new capital, although Ventracor held discussions with more than 100 prospective investors. US-based Medtronic is believed to be a potential buyer of the group's VentrAssist heart pump technology. ###########################################################
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.